Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
MENLO PARK, Calif., April 29, 2024 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the...